PATH participates in conference on sexually transmitted infections

July 31, 2007 by PATH

Premier scientific conference to address research on HIV, cervical cancer, and other diseases

PATH staff will present their work to more than a thousand experts attending the 17th annual meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), being held in Seattle from July 29 to August 1.

Since its inception, PATH has been involved in ensuring the availability and quality of barrier protection devices, such as condoms and diaphragms. Over the last two decades, PATH has conducted cutting-edge research aimed at providing early and accurate diagnosis of sexually transmitted infections (STIs) and reducing the risk of their transmission.

At the conference, Dr. Jacqueline Sherris, vice president of global programs, will share PATH’s experience introducing a vaccine against cervical cancer in a panel entitled “HPV vaccine: immunobiology and implementation.” Several other PATH staff will present posters about various areas of research, including STI management in Bolivia and the development of a screening test for cervical cancer.

ISSTDR exists to promote research on STIs and facilitate the timely exchange of information among research investigators. Held biannually in venues that alternate between Europe and North America, the ISSTDR meetings are regarded as premier scientific conferences that address the entire breadth of research on STIs, including the virus that causes HIV and AIDS.

Experts from around the globe will gather to attend sessions that encompass microbiology, virology, immunobiology, pathogenesis, other clinical sciences, social and behavioral sciences, epidemiology, and disease prevention.

Posted July 31, 2007.